Therefore, we postulate that the inhibitory effects of SC-1 might provide an intervention point to arrest the vicious circle of the autocrine feed-forward loops between IL-6 and TGFβ during tumorigenesis and to stimulate possible strategies for cancer treatment. The gene discussed is TGFB1; the disease is cancer.